Literature DB >> 8996527

Amelioration of methotrexate-induced malabsorption by vitamin A.

J Yamamoto1, T Horie, S Awazu.   

Abstract

Methotrexate (MTX) induces damage to the small intestine, resulting in malabsorption and diarrhea. We found that the coadministration of vitamin A (VA) with MTX protected the small intestine from MTX-induced damage. In this study, the permeability of D-glucose, D-xylose and L-leucine through the small intestine of rats treated with MTX and/or VA was studied using everted segments of small intestine. MTX treatment decreased permeability and VA coadministration prevented the decrease. The transport of D-glucose in the small intestine of MTX plus VA- and VA-treated rats and of control rats followed Michaelis-Menten kinetics, in contrast to the transport kinetics in MTX-treated rats. The pharmacokinetics of orally administered [14C]-D-glucose in control rats and MTX- and/or VA-treated rats was also studied. The bioavailability of D-glucose in MTX-treated rats was lower than in the other three groups. VA coadministration improved the bioavailability of D-glucose. Thus, it seems likely that VA ameliorates MTX-induced malabsorption.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8996527     DOI: 10.1007/s002800050567

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  3 in total

1.  Phase II trial of oral aminopterin for adults and children with refractory acute leukemia.

Authors:  Peter D Cole; Richard A Drachtman; Angela K Smith; Sarah Cate; Richard A Larson; Douglas S Hawkins; John Holcenberg; Kara Kelly; Barton A Kamen
Journal:  Clin Cancer Res       Date:  2005-11-15       Impact factor: 12.531

2.  Does vitamin A prevent high-dose-methotrexate-induced D-xylose malabsorption in children with cancer?

Authors:  Ayhan Dagdemir; Hasan Yildirim; Yuksel Aliyazicioglu; Yilmaz Kanber; Davut Albayrak; Sabri Acar
Journal:  Support Care Cancer       Date:  2004-02-06       Impact factor: 3.603

3.  Lutein protects against methotrexate-induced and reactive oxygen species-mediated apoptotic cell injury of IEC-6 cells.

Authors:  Chi-Jen Chang; Ji-Fan Lin; Hsun-Hsien Chang; Gon-Ann Lee; Chi-Feng Hung
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.